IP Library Assignment 065676/0617
Patent Assignment
Reel/Frame 065676/0617

Notice of Grant of Security Interest in Patents

Recorded: 2023-11-27 Pages: 13
Assignor
RVL PHARMACEUTICALS, INC.
Executed: 2023-11-22
Assignee
ATHYRIUM OPPORTUNITIES IV ACQUISITION LP, AS ADMINISTRATIVE AGENT
505 FIFTH AVENYE, FLOOR 18, NEW YORK, NEW YORK, 10017
Covered Properties (20)
Compositions and Methods for Treating Blepharoptosis
Application: 62/843,819 →
Compositions and Methods for Treating Blepharoptosis
Application: 62/844,069 →
Oxymetazoline Compositions
Application: 18/146,127 →
Publication: US 2023/0355587
Compositions and Methods for Treating Ocular Disorders
Application: 18/331,688 →
Publication: US 2024/0033250
Refrigerator, Ice Maker for a Refrigerator, and Method for Making Ice
Application: 13/218,587 →
Publication: US 2011/0302951
Compositions and Methods for Non-Surgical Treatment of Ptosis
Application: 15/837,325 →
Publication: US 2018/0338953
Compositions and Methods for Non-Surgical Treatment of Ptosis
Application: 16/892,645 →
Publication: US 2020/0360345
Oxymetazoline Compositions
Application: 16/715,998 →
Publication: US 2020/0353083
Compositions and Methods for Treating Ocular Disorders
Application: 16/716,014 →
Oxymetazoline Compositions
Application: 17/154,676 →
Publication: US 2021/0137889
Compositions and Methods for Treating Ocular Disorders
Application: 17/194,559 →
Publication: US 2021/0212992
Oxymetazoline Compositions
Application: 17/064,915 →
Publication: US 2021/0023222
Compositions and Methods for Treating Ocular Disorders
Application: 17/063,416 →
Publication: US 2021/0015795
Oxymetazoline Compositions
Application: 17/461,052 →
Publication: US 2021/0386711
Compositions and Methods for Treating Ocular Disorders
Application: 17/662,494 →
Publication: US 2022/0273621
Oxymetazoline Compositions
Application: 17/728,860 →
Publication: US 2022/0257566
Compositions and Methods for Non-Surgical Treatment of Ptosis
Patent: 8,357,714 →
Application: 13/270,577 →
Publication: US 2012/0225919
Compositions and Methods for Non-Surgical Treatment of Ptosis
Patent: 9,018,240 →
Application: 13/408,364 →
Publication: US 2012/0225920
Compositions and Methods for Non-Surgical Treatment of Ptosis
Patent: 9,867,808 →
Application: 14/625,099 →
Publication: US 2016/0038465
Compositions and Methods for Non-Surgical Treatment of Ptosis
Application: 16/577,262 →
Publication: US 2020/0009114
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 7, 2011
From: SILVERBERG, MARK
To: VOOM, LLC
Reel/Frame 027184/0486 →
Assignment of Assignor's Interest Apr 2, 2012
From: SILVERBERG, MARK
To: VOOM, LLC
Reel/Frame 027971/0914 →
Assignment of Assignor's Interest Apr 15, 2015
From: SILVERBERG, MARK
To: VOOM, LLC
Reel/Frame 035414/0163 →
Assignment of Assignor's Interest Sep 11, 2018
From: SILVERBERG, MARK
To: VOOM, LLC
Reel/Frame 046835/0189 →
Assignment of Assignor's Interest Sep 26, 2019
From: SILVERBERG, MARK
To: VOOM, LLC
Reel/Frame 050498/0415 →
Assignment of Assignor's Interest Feb 27, 2020
From: DEVRIES, TINA; JACOBS, DAVID
To: REVITALID, INC.
Reel/Frame 051955/0105 →
Change of Name May 5, 2020
From: REVITALID, INC.
To: RVL PHARMACEUTICALS, INC.
Reel/Frame 052578/0827 →
Security Interest May 22, 2020
From: RVL PHARMACEUTICALS, INC.
To: CIT BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 052734/0192 →
Assignment of Assignor's Interest Aug 25, 2020
From: SILVERBERG, MARK
To: VOOM, LLC
Reel/Frame 053590/0395 →
Assignment of Assignor's Interest Oct 7, 2020
From: DEVRIES, TINA; JACOBS, DAVID
To: REVITALID, INC.
Reel/Frame 053997/0850 →
Change of Name Oct 7, 2020
From: REVITALID, INC.
To: RVL PHARMACEUTICALS, INC.
Reel/Frame 054001/0419 →
Assignment of Assignor's Interest Oct 7, 2020
From: DEVRIES, TINA; JACOBS, DAVID
To: REVITALID, INC.
Reel/Frame 054000/0603 →
Change of Name Oct 7, 2020
From: REVITALID, INC.
To: RVL PHARMACEUTICALS, INC.
Reel/Frame 054005/0623 →
Security Interest Jan 25, 2021
From: RVL PHARMACEUTICALS, INC.
To: CIT BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 055015/0762 →
Security Interest Jun 30, 2021
From: RVL PHARMACEUTICALS, INC.
To: CIT BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 056724/0588 →
Assignment of Assignor's Interest Jul 28, 2021
From: DEVRIES, TINA; JACOBS, DAVID
To: REVITALID, INC.
Reel/Frame 057004/0526 →
Change of Name Jul 28, 2021
From: REVITALID, INC.
To: RVL PHARMACEUTICALS, INC.
Reel/Frame 057012/0735 →
Assignment of Assignor's Interest Sep 1, 2021
From: DEVRIES, TINA; JACOBS, DAVID
To: REVITALID, INC.
Reel/Frame 057357/0850 →
Change of Name Sep 1, 2021
From: REVITALID, INC.
To: RVL PHARMCEUTICALS, INC.
Reel/Frame 057393/0665 →
Change of Name Sep 1, 2021
From: REVITALID, INC.
To: RVL PHARMCEUTICALS, INC.
Reel/Frame 057393/0621 →
Assignment of Assignor's Interest Sep 1, 2021
From: DEVRIES, TINA; JACOBS, DAVID
To: REVITALID, INC.
Reel/Frame 057357/0415 →
Notice of Grant of Security Interest in Patents Oct 12, 2021
From: RVL PHARMACEUTICALS, INC.
To: ATHYRIUM OPPORTUNITIES IV ACQUISITION LP, AS ADMINISTRATIVE AGENT
Reel/Frame 057787/0507 →
Release of Patent Security Agreements Oct 15, 2021
From: CIT BANK, N.A., AS COLLATERAL AGENT
To: RVL PHARMACEUTICALS, INC.
Reel/Frame 057819/0436 →
Release of Security Interest Oct 15, 2021
From: CIT BANK, N.A.
To: RVL PHARMACEUTICALS, INC.
Reel/Frame 057801/0484 →
Corrective Assignment to Correct the the Receiving Party Data Previously Recorded on Reel 057393 Frame 0621. Assignor(S) Hereby Confirms the Change of Name. Jun 9, 2022
From: REVITALID, INC.
To: RVL PHARMACEUTICALS, INC.
Reel/Frame 060555/0218 →